Racemic adrenaline and inhalation strategies in acute bronchiolitis
- PMID: 23758233
- DOI: 10.1056/NEJMoa1301839
Racemic adrenaline and inhalation strategies in acute bronchiolitis
Abstract
Background: Acute bronchiolitis in infants frequently results in hospitalization, but there is no established consensus on inhalation therapy--either the type of medication or the frequency of administration--that may be of value. We aimed to assess the effectiveness of inhaled racemic adrenaline as compared with inhaled saline and the strategy for frequency of inhalation (on demand vs. fixed schedule) in infants hospitalized with acute bronchiolitis.
Methods: In this eight-center, randomized, double-blind trial with a 2-by-2 factorial design, we compared inhaled racemic adrenaline with inhaled saline and on-demand inhalation with fixed-schedule inhalation (up to every 2 hours) in infants (<12 months of age) with moderate-to-severe acute bronchiolitis. An overall clinical score of 4 or higher (on a scale of 0 to 10, with higher scores indicating more severe illness) was required for study inclusion. Any use of oxygen therapy, nasogastric-tube feeding, or ventilatory support was recorded. The primary outcome was the length of the hospital stay, with analyses conducted according to the intention-to-treat principle.
Results: The mean age of the 404 infants included in the study was 4.2 months, and 59.4% were boys. Length of stay, use of oxygen supplementation, nasogastric-tube feeding, ventilatory support, and relative improvement in the clinical score from baseline (preinhalation) were similar in the infants treated with inhaled racemic adrenaline and those treated with inhaled saline (P>0.1 for all comparisons). On-demand inhalation, as compared with fixed-schedule inhalation, was associated with a significantly shorter estimated mean length of stay--47.6 hours (95% confidence interval [CI], 30.6 to 64.6) versus 61.3 hours (95% CI, 45.4 to 77.2; P=0.01) - as well as less use of oxygen supplementation (in 38.3% of infants vs. 48.7%, P=0.04), less use of ventilatory support (in 4.0% vs. 10.8%, P=0.01), and fewer inhalation treatments (12.0 vs. 17.0, P<0.001).
Conclusions: In the treatment of acute bronchiolitis in infants, inhaled racemic adrenaline is not more effective than inhaled saline. However, the strategy of inhalation on demand appears to be superior to that of inhalation on a fixed schedule. (Funded by Medicines for Children; ClinicalTrials.gov number, NCT00817466; EudraCT number, 2009-012667-34.).
Comment in
-
Inhaled adrenaline in acute bronchiolitis.N Engl J Med. 2013 Sep 12;369(11):1076-7. doi: 10.1056/NEJMc1308964. N Engl J Med. 2013. PMID: 24024851 No abstract available.
-
Inhaled adrenaline in acute bronchiolitis.N Engl J Med. 2013 Sep 12;369(11):1075-6. doi: 10.1056/NEJMc1308964. N Engl J Med. 2013. PMID: 24024852 No abstract available.
-
Inhaled adrenaline in acute bronchiolitis.N Engl J Med. 2013 Sep 12;369(11):1076. doi: 10.1056/NEJMc1308964. N Engl J Med. 2013. PMID: 24024853 No abstract available.
-
On-demand, not scheduled, nebulization (epinephrine or saline) improves important clinical outcomes in hospitalized infants with bronchiolitis.J Pediatr. 2013 Nov;163(5):1529-30. doi: 10.1016/j.jpeds.2013.08.055. J Pediatr. 2013. PMID: 24160663 No abstract available.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical